- Filed
- Feb 12, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2026 · Feb 6, 2026 | 34.35M sh |
| Shares Diluted | Q2 2026 · Dec 31, 2025 | 45.97M sh |
| Shares Diluted | Q2 2026 · Dec 31, 2025 | 43.75M sh |
| Shares Diluted restated | Q2 2026 · Dec 31, 2024 | 37.25M sh |
| Shares Diluted restated | Q2 2026 · Dec 31, 2024 | 32.57M sh |
| Capex | Q2 2026 · Dec 31, 2025 | $11K |
| Capex | Q2 2026 · Dec 31, 2024 | $12K |
| Operating Cash Flow | Q2 2026 · Dec 31, 2025 | −$7.13M |
| Operating Cash Flow | Q2 2026 · Dec 31, 2024 | −$12.29M |
| Cash And Equivalents | Q2 2026 · Dec 31, 2025 | $188.79M |
| Cash And Equivalents | Q2 2026 · Jun 30, 2025 | $97.74M |
| Stockholders Equity | Q2 2026 · Dec 31, 2025 | $187.36M |
| Stockholders Equity | Q2 2026 · Sep 30, 2025 | $93.6M |
| Stockholders Equity | Q2 2026 · Jun 30, 2025 | $97.3M |
| Stockholders Equity | Q2 2026 · Dec 31, 2024 | $75.94M |
| Stockholders Equity | Q2 2026 · Sep 30, 2024 | $64.18M |
| Stockholders Equity | Q2 2026 · Jun 30, 2024 | $47.25M |
| Current Liabilities | Q2 2026 · Dec 31, 2025 | $2.8M |
| Current Liabilities | Q2 2026 · Jun 30, 2025 | $1.8M |
| Total Liabilities | Q2 2026 · Dec 31, 2025 | $3.32M |
| Total Liabilities | Q2 2026 · Jun 30, 2025 | $2.3M |
| Current Assets | Q2 2026 · Dec 31, 2025 | $189.6M |
| Current Assets | Q2 2026 · Jun 30, 2025 | $98.52M |
| Total Assets | Q2 2026 · Dec 31, 2025 | $190.68M |
| Total Assets | Q2 2026 · Jun 30, 2025 | $99.59M |
| Eps Diluted | Q2 2026 · Dec 31, 2025 | −$0.26 |
| Eps Diluted | Q2 2026 · Dec 31, 2025 | −$0.48 |
| Eps Diluted restated | Q2 2026 · Dec 31, 2024 | −$0.26 |
| Eps Diluted restated | Q2 2026 · Dec 31, 2024 | −$0.45 |
| Eps Basic | Q2 2026 · Dec 31, 2025 | −$0.26 |
| Eps Basic | Q2 2026 · Dec 31, 2025 | −$0.48 |
| Eps Basic restated | Q2 2026 · Dec 31, 2024 | −$0.26 |
| Eps Basic restated | Q2 2026 · Dec 31, 2024 | −$0.45 |
| Sga Expense | Q2 2026 · Dec 31, 2025 | $7.54M |
| Sga Expense | Q2 2026 · Dec 31, 2025 | $13.98M |
| Sga Expense restated | Q2 2026 · Dec 31, 2024 | $5.42M |
| Sga Expense restated | Q2 2026 · Dec 31, 2024 | $7.63M |
| Rd Expense | Q2 2026 · Dec 31, 2025 | $5.83M |
| Rd Expense | Q2 2026 · Dec 31, 2025 | $9.2M |
| Rd Expense restated | Q2 2026 · Dec 31, 2024 | $5.39M |
| Rd Expense restated | Q2 2026 · Dec 31, 2024 | $8.97M |
| Net Income | Q2 2026 · Dec 31, 2025 | −$11.84M |
| Net Income | Q2 2026 · Dec 31, 2025 | −$20.8M |
| Net Income | Q2 2026 · Sep 30, 2025 | −$8.97M |
| Net Income restated | Q2 2026 · Dec 31, 2024 | −$9.55M |
| Net Income restated | Q2 2026 · Dec 31, 2024 | −$14.61M |
| Net Income | Q2 2026 · Sep 30, 2024 | −$5.06M |
| Operating Income | Q2 2026 · Dec 31, 2025 | −$13.38M |
| Operating Income | Q2 2026 · Dec 31, 2025 | −$23.18M |
| Operating Income restated | Q2 2026 · Dec 31, 2024 | −$10.81M |
| Operating Income restated | Q2 2026 · Dec 31, 2024 | −$16.6M |
| Revenue | Q2 2026 · Dec 31, 2025 | $0 |
| Revenue | Q2 2026 · Dec 31, 2025 | $0 |
| Revenue | Q2 2026 · Dec 31, 2024 | $0 |
| Revenue | Q2 2026 · Dec 31, 2024 | $0 |